Genmab A/S

Genmab A/S Dividend Coverage

Dividend Coverage Ratio of Genmab A/S (GMAB.CO) as of Sep 27, 2026.

Dividend Coverage

-

Last updated:

Dividend Coverage Ratio of Genmab A/S is 2026 - . Dividend Coverage Ratio of Genmab A/S was 2025 - . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Genmab A/S since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Genmab A/S historically and in real time.

Access this data via the Eulerpool API

Dividend — Genmab A/S

All Key Metrics — Genmab A/S